BOSTON--(BUSINESS WIRE)--OM1, a leading real-world data, outcomes, and technology company with a focus on chronic conditions, today announced the launch of two new Real-World Analytics products – ...
BOSTON--(BUSINESS WIRE)--OM1, a leading real-world data, outcomes and technology company with a focus on chronic conditions, today launched PhenOM™, its artificial intelligence-powered platform for ...
OM1, a Boston-based artificial intelligence platform for clinical real-world evidence, has raised $50 million in Series C funding. Scale Venture Partners led the round consisting of support from prior ...
We're living at a crossroads in healthcare, with AI set to revolutionize personalized medicine and improve patient care. This transformative moment mirrors previous technological medical revolutions, ...
Boston-based health outcomes and tech company OM1 has just announced that it raked in $21 million in a Series B financing round led by Polaris Partners with participation from existing investors ...
OM1, a company that provides chronic disease registries and real-world data, banked $85 million backed by Kaiser Permanente and General Catalyst. The Boston-based health technology company says it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results